×
For best experience we recommend to activate Javascript in your browser.
PLA2G4A antibody (Biotin)
The Biotin-conjugated Rabbit Polyclonal anti-PLA2G4A antibody (ABIN6352743) specifically detects PLA2G4A in WB, IHC and IF/ICC.
The antibody is reactive with Human samples.
Catalog No. ABIN6352743
$565.06
Plus shipping costs $50.00
1 mL ABIN6352744
200 μL ABIN6352743
1 mL ABIN6352744
200 μL ABIN6352743
Delivery in 10 to 20 Business Days
Quick Overview for PLA2G4A antibody (Biotin) (ABIN6352743)
Target
See all PLA2G4A Antibodies
PLA2G4A
(Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
Reactivity
All reactivities for PLA2G4A antibodies
Human
Host
All hosts for PLA2G4A antibodies
Rabbit
Clonality
All clonalities for PLA2G4A antibodies
Polyclonal
Conjugate
All conjugates for PLA2G4A antibodies
This PLA2G4A antibody is conjugated to Biotin
Application
All applications for PLA2G4A antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (fixed cells) (IF/ICC)
Product Details anti-PLA2G4A Antibody (Biotin)
(hide)
Purification
Purified by antigen-specific affinity chromatography followed by Protein A affinity chromatography
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
200 μg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
Store at 4 °C. Avoid exposure to light.
Target Details for PLA2G4A
(hide)
Target
PLA2G4A
(Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
Alternative Name
Phospholipase A2, Cytosolic
Pathways
Inositol Metabolic Process , G-protein mediated Events , VEGF Signaling
Recently viewed
(hide)
You are here:
Homepage
anti-PLA2G4A antibody (Biotin) (ABIN6352743)
Chat with us , powered by LiveChat